
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
ALGERNON PHARMACEUT. A AGW0 CA01559R4008
AB/FROM ONWARDS 28.03.2024 08:09 CET
© 2024 Xetra Newsboard
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
25.02. | Algernon Yau: 10K Foreign Firms Settle in HK Last Yr, Up 10% YoY | ||
11.02. | Algernon Pharmaceuticals Inc (2): Algernon Neuro appoints Nardai as phase 2a DMT study PI | ||
05.02. | Algernon Pharmaceuticals Inc (2): Algernon unit appoints Validcare as CRO for DMT study | ||
05.02. | Algernon Pharmaceuticals Inc.: Algernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial and Announces Validcare's USD $170K Equity Investment | VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the "Company" or "AGN Pharma") (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage... ► Artikel lesen | |
06.01. | Algernon Pharmaceuticals Inc (2): Algernon receives U.S. patent allowance for NP-251 |
Unternehmen / Aktien | Kurs | % |
---|---|---|
ALGERNON PHARMACEUTICALS INC | 0,026 | -28,77 % |